The Chemours Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2025: -80.89%

The Chemours Company Return on Equity (ROE) is -80.89% for the Trailing 12 Months (TTM) ending June 30, 2025, a -617.22% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • The Chemours Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2024 was 15.64%, a -296.64% change year over year.
  • The Chemours Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2023 was -7.95%, a -110.05% change year over year.
  • The Chemours Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2022 was 79.12%, a 153.45% change year over year.
  • The Chemours Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2021 was 31.22%, a -289.31% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share